Science News
from research organizations

Hormone that predicts premature death in kidney patients identified

September 9, 2011
University of Colorado Denver
Researchers have discovered a hormone that can predict early death in kidney patients.

Researchers at the University of Colorado School of Medicine have found that high levels of a specific hormone can predict which kidney patients will develop heart problems, require dialysis or die prematurely.

"This discovery allows us to predict at-risk patients before they require dialysis," said lead investigator Michel Chonchol, MD, an associate professor of medicine specializing in nephrology. "That's critical because approximately 23 percent of patients on dialysis die in the first year."

The findings were published September 9 in the Journal of the American Society of Nephrology.

Chonchol and fellow CU School of Medicine researcher Jessica Kendrick, MD, studied the blood plasma of patients with advanced kidney disease and found that levels of fibroblast growth factor-23, a hormone known as FGF-23, increased as the patient's kidney function decreased.

The hormone regulates phosphorus levels in the body. As the kidneys fail, they are unable to excrete phosphorus which raises FGF-23 levels. The higher the hormone levels, the greater chance the patient will die.

"At this point we don't know how the hormone changes the body," Chonchol said.

By the time a patient is down to just 30 or 40 percent kidney function, the levels of FGF-23 can predict who will die, have a cardiac event or end up on dialysis. Almost 50 percent of the deaths result from cardiovascular issues like heart attack.

Until now, doctors relied on measuring phosphorus to assess phosphate balance in patients with kidney disease.

"Prior to a patient going on dialysis the phosphorus levels shoot up," Chonchol said.

But he found that long before phosphorus levels jump, FGF-23 levels have already increased. Identifying this earlier will allow doctors to intervene with drugs that can lower phosphorus which would then lower the hormone level.

"This has provided us a critical marker to look for," Chonchol said, "A marker that could save lives."

Kidney disease currently afflicts 20 million Americans and is a growing problem as the nation gets increasingly obese and diabetes continues to rise.

"The best ways to prevent kidney disease is through blood pressure control, diet, exercise and maintaining a healthy body weight," Chonchol said.

Story Source:

The above post is reprinted from materials provided by University of Colorado Denver. Note: Materials may be edited for content and length.

Journal Reference:

  1. J. Kendrick, A. K. Cheung, J. S. Kaufman, T. Greene, W. L. Roberts, G. Smits, M. Chonchol. FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis. Journal of the American Society of Nephrology, 2011; DOI: 10.1681/ASN.2010121224

Cite This Page:

University of Colorado Denver. "Hormone that predicts premature death in kidney patients identified." ScienceDaily. ScienceDaily, 9 September 2011. <>.
University of Colorado Denver. (2011, September 9). Hormone that predicts premature death in kidney patients identified. ScienceDaily. Retrieved November 25, 2015 from
University of Colorado Denver. "Hormone that predicts premature death in kidney patients identified." ScienceDaily. (accessed November 25, 2015).

Share This Page: